• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rifampicin-induced immune allergic reaction.

作者信息

Sadanshiv Mahima, George Anu Anna, Mishra Ajay Kumar, Kuriakose Cijoy K

机构信息

1 Resident, Department of Internal Medicine, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

2 Assistant Professor, Department of Dermatology, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.

出版信息

Trop Doct. 2018 Apr;48(2):156-159. doi: 10.1177/0049475517724689. Epub 2017 Aug 1.

DOI:10.1177/0049475517724689
PMID:28764592
Abstract
摘要

相似文献

1
Rifampicin-induced immune allergic reaction.
Trop Doct. 2018 Apr;48(2):156-159. doi: 10.1177/0049475517724689. Epub 2017 Aug 1.
2
Clinical pharmacokinetic considerations in the treatment of patients with leprosy.麻风病患者治疗中的临床药代动力学考量
Clin Pharmacokinet. 1989 Jun;16(6):365-86. doi: 10.2165/00003088-198916060-00003.
3
Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.氯法齐明和氨苯砜对多菌型和少菌型麻风病例中利福平（力复平）药代动力学的影响。
Indian J Lepr. 1985 Apr-Jun;57(2):297-310.
4
Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention.卡介苗接种和利福平预防在麻风病预防中的保护作用。
Vaccine. 2009 Nov 23;27(50):7125-8. doi: 10.1016/j.vaccine.2009.09.054. Epub 2009 Sep 26.
5
Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.单剂量利福平作为麻风病暴露后预防用药诱导结核分枝杆菌耐药的风险可忽略不计。
Infect Dis Poverty. 2016 Jun 8;5(1):46. doi: 10.1186/s40249-016-0140-y.
6
Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.针对多菌型麻风病患者，采用含氧氟沙星和利福平方案的联合化疗试验。
J Med Assoc Thai. 1996 Apr;79(4):210-7.
7
Reversible acute renal failure due to monthly administration of rifampicin in a leprosy patient.
Indian J Lepr. 1984 Oct-Dec;56(4):835-9.
8
Leprosy nephropathy: a review of clinical and histopathological features.麻风肾病：临床与组织病理学特征综述
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):15-20. doi: 10.1590/S0036-46652015000100002.
9
Effect of probenecid on serum rifampicin levels.丙磺舒对血清利福平水平的影响。
Indian J Lepr. 1985 Apr-Jun;57(2):329-33.
10
Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
Lepr India. 1980 Jul;52(3):359-65.

引用本文的文献

1
[Not Available].[无可用内容]
CMAJ. 2023 Nov 6;195(43):E1489-E1491. doi: 10.1503/cmaj.230317-f.
2
Rifampin-induced flu-like syndrome with shock in a patient with tuberculosis infection.一名结核感染患者出现利福平诱导的流感样综合征并伴有休克。
CMAJ. 2023 Sep 5;195(34):E1151-E1153. doi: 10.1503/cmaj.230317.
3
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective.COVID-19与结核病：揭示双重威胁及共同应对方案视角
J Clin Med. 2023 Jul 19;12(14):4784. doi: 10.3390/jcm12144784.
4
Pathogenesis of SARS-CoV-2 and Coinfection.SARS-CoV-2 的发病机制及合并感染。
Front Immunol. 2022 Jun 16;13:909011. doi: 10.3389/fimmu.2022.909011. eCollection 2022.
5
Mechanism of COVID-19-Related Proteins in Spinal Tuberculosis: Immune Dysregulation.COVID-19 相关蛋白在脊柱结核中的作用机制：免疫失调。
Front Immunol. 2022 Jun 2;13:882651. doi: 10.3389/fimmu.2022.882651. eCollection 2022.
6
Rifampicin for COVID-19.用于治疗新冠肺炎的利福平
World J Virol. 2022 Mar 25;11(2):90-97. doi: 10.5501/wjv.v11.i2.90.
7
Tuberculosis and COVID-19 Co-infection: An Updated Review.结核病与 COVID-19 双重感染：最新综述。
Acta Biomed. 2020 Nov 10;92(1):e2021025. doi: 10.23750/abm.v92i1.10738.
8
Rifampicin: not always an innocent drug.利福平：并非总是无害的药物。
BMJ Case Rep. 2018 Dec 9;11(1):e227356. doi: 10.1136/bcr-2018-227356.
9
Rifampicin-Induced Fever in a Patient with Brucellosis: A Case Report.利福平诱发布鲁氏菌病患者发热：一例报告
Drug Saf Case Rep. 2018 Feb 9;5(1):9. doi: 10.1007/s40800-018-0074-3.